Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Uber Eats Adds Sur La Table to Retail Marketplace

Uber Eats Adds Sur La Table to Retail Marketplace

MT newswireMT newswire2026/10/08 12:44

08:44 AM EDT, 10/08/2026 (MT Newswires) -- Uber Technologies (UBER) said Thursday that Sur La Table has joined Uber Eats, allowing customers to order cookware, appliances and kitchen accessories from its US stores for on-demand or scheduled delivery. The partnership covers all Sur La Table locations nationwide, with delivery available in as little as 25 minutes, it said. Customers can access brands including Le Creuset and All-Clad through the Uber Eats app, expanding the platform's retail offerings beyond food, it added.

08:44 AM EDT, 10/08/2026 (MT Newswires) -- Uber Technologies (UBER) said Thursday that Sur La Table has joined Uber Eats, allowing customers to order cookware, appliances and kitchen accessories from its US stores for on-demand or scheduled delivery. The partnership covers all Sur La Table locations nationwide, with delivery available in as little as 25 minutes, it said. Customers can access brands including Le Creuset and All-Clad through the Uber Eats app, expanding the platform's retail offerings beyond food, it added.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss